
Posted: September 2026
ARA-290 is a synthetic peptide derived from the structure of erythropoietin, engineered to interact with the innate repair receptor rather than hematopoietic pathways. Its receptor-selectivity design has made it a frequently referenced compound in tissue-signaling research.
This overview is intended for educational and research information purposes only.
Laboratory interest in ARA-290 centers on its erythropoietin-derived structure and its role in innate repair receptor research models.
Researchers frequently examine:
Its structural design โ intended to engage the innate repair receptor while minimizing hematopoietic-pathway activity โ makes it a frequently referenced compound in receptor-selectivity research.
Comparative researchers frequently examine how receptor-selective structural design may relate to innate repair receptor research models.
Research interest frequently includes:
Researchers frequently compare ARA-290 with other research peptides to evaluate:
Consistent handling procedures support research reproducibility:
ARA-290 is supplied for laboratory research applications and educational research purposes only.
No. Research materials supplied by Priority Aminos are not intended for human or veterinary use.
Lot coding supports traceability, documentation, and internal quality procedures.
Comparative analysis may help researchers evaluate differences in structural origin, stability, and research-model design.
Consistent storage procedures help maintain documentation standards and improve research consistency.
Research Use Only (RUO). Not for human or veterinary use.
Join our research newsletter for early access to new compounds and COA updates. We'll send a one-time 10% discount code to your inbox.
Research use only (RUO). No spam โ unsubscribe anytime.